This daily electronic briefing delivers coverage of what’s happening on
Capitol Hill and at the FDA, FTC, HHS, NIH and other key agencies and
decision-making bodies that affect the pharmaceutical industry. Each
issue gives you hard reporting on top issues, such as drug-safety
oversight, clinical trial registries, adverse event reporting and
warning letters. Written by FDAnews’ veteran staff of reporters, you
get the news as it happens with the added perspective that only
seasoned reporters can provide. It’s the fastest, most reliable way to
make sure you’re an industry expert.
Daily, 30-day electronic trial subscription
